OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 02, 2018
Catalent completes $4.6 million expansion at Singapore clinical supply facility and marks 20 years in the region.
Development and adoption of new technologies create challenges that may take years to resolve.
Assessing potential formulation and manufacturing issues in early development phases can improve a drug’s chances for success.
Robert Iser of PAREXEL Consulting answers questions regarding the regulatory expectations of quality agreements and how companies can ensure the quality and safety of their products.
February 23, 2018
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
February 22, 2018
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
The company aims to add the additional analytical services in the European Union throughout 2018.
February 21, 2018
Automation systems, vehicles, and robots improve efficiency of transporting materials and finished goods in pharmaceutical warehouses.
February 20, 2018
A new suite for the encapsulation of highly potent drugs will be added.
February 13, 2018
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.